DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jbfbkh/apac_contract) has announced the addition of the "APAC Contract Research Organisation (CRO) Market" report to their offering.
The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-clinical trials to post marketing surveillance.
Moreover, it provides detailed information on support services such as central laboratory services, bio-analytics, and data management. The research service also analyses market drivers and restraints, and provides market engineering measurements and research and development trends.
Outsourcing to low-cost locations is likely to result in lesser margins in the short term, but in higher volume share. However, with increased capacity and scale, companies are expected to improve their margins during the rest of the forecast period.
Specialised services such as eClinical trial solutions, adaptive trial designs, and outcomes research are expected to transform the way clinical trials are performed currently.
Spending on R&D is growing tremendously in APAC, driven by increased globalisation of the pharmaceutical and biotechnology markets and low-cost advantage, which support volume growth.
Mergers and acquisitions (M&A) will continue to drive consolidation in the CRO market; larger companies will continue to expand through acquisition. The merger of Clinipace Worldwide with Choice Pharma (a Pan-Asian CRO company) and acquisition of Pacific Clinical Research (a Pan-Asian CRO company) by Chiltern are examples of aggressive expansion strategies.
Key Topics Covered:
1. Executive Summary
2. Market Overview
3. Competitive Playbook
4. Drivers, Restraints, and Trends
5. Forecasts and Trends - Total CRO Market
6. Competitive Environment
7. Pre-Clinical Trials Segment Breakdown
8. Phase I Trials Segment Breakdown
9. Phase II Trials Segment Breakdown
10. Phase III Trials Segment Breakdown
11. Phase IV Trials Segment Breakdown
12. Data Management Segment Breakdown
13. Biostatistics Segment Breakdown
14. Pharmacovigilance Segment Breakdown
15. Health Economics and Outcomes Research (HEOR) Segment Breakdown
16. Bio-Analytics Segment
17. Central Laboratory Services Segment Breakdown
18. The Last Word
19. Appendix
Companies Mentioned
- Chiltern
- Choice Pharma
- Clinipace Worldwide
- Covance
- PPD
- PRA Health Sciences
- Pacific Clinical Research
- Parexel
For more information visit http://www.researchandmarkets.com/research/jbfbkh/apac_contract
